Dear Kratom Warriors,

The fight to keep kratom legal is getting more and more intense and once again, we need your help to send a loud message to the folks at the DEA and on Capitol Hill.

Please click on the link within this email to sign the petition requesting that DEA Acting Administrator Uttam Dhillon immediately return the 8-Factor Analysis submitted by the FDA and reject their recommendation to schedule kratom as a Schedule 1 substance.

With almost constant rumors and threats of an imminent Scheduling, it’s critical that we all stand with one loud voice and declare that we won’t back down.

They need to stop the War on Kratom.

We need to make it clear that we will not be silent and that we will continue to keep up the pressure.

Help us surpass our goal of 40,000 signatures on this petition.  Please share this email with friends, family, or anyone who believes we should keep our rights to make our own decisions about our health and well-being.

Together we can win this fight!



Acting Administrator Dhillon:
As one of nearly 5 million kratom users in the United States, the undersigned each respectfully requests that the Drug Enforcement Administration (DEA) immediately return the 8-Factor Analysis submitted by the U.S. Food and Drug Administration (FDA) and reject their recommendation to schedule kratom as a Schedule I substance under the Controlled Substances Act (CSA). The cloud over kratom needs to be removed immediately.

We ask the DEA to Follow the Science to protect access to kratom by those Americans who exercise their freedoms to safely use kratom as a part of their personal health and well-being regimen. The claims of deaths “associated with the use of kratom” made by the FDA have been discredited and now requires a complete reanalysis of actual risks that may exist for the use of kratom.

The DEA cannot allow the FDA to recommend scheduling of the natural plant kratom with shoddy evidence that demonstrates only that kratom products are potentially harmful when they are contaminated or adulterated with other dangerous substances, or the active alkaloids in kratom are concentrated or refined to dangerous levels.

The FDA’s claims that kratom use is a gateway to the use of opioids, or the contributor for addiction to opioids, has no credible science to support that claim.  In fact, the science and survey data on kratom use by those who use kratom as a safe alternative pain management option directly contradicts the FDA’s claims. The FDA should be required to provide real evidence, not opinion, speculation, or unsupported guesses.

We urge the DEA to Follow the Science.
Respectfully submitted,

American Kratom Association
5501 Merchants View Square #202
Haymarket, VA [email protected]